PubMed Health⌕ Search

Biomedical subjects

E Narimatsu

Publications and source records attributed to E Narimatsu.

At least 37 records · Page 2Linked to original sources

[Intra-arterial infusion chemotherapy for advanced or recurrent breast cancers].

Ideally, in preoperative intra-arterial infusion chemotherapy (regarding advanced breast cancer) is to obtain the most significant effects concerning histological features. Intra-arterial infusion chemotherapy using epirubicin (EPI), used in conjunction with daily doses of 1,200 mg medroxyprogesterone acetate (MPA), have recently been performed. This procedure has shown remarkable histological effects in the metastatic lymph nodes as well as in the primary lesions. These results were especially remarkable in the patients who were administered MPA (daily) two weeks prior to EPI infusion. These patients showed a complete disappearance of tumor cells. The results were interesting in view of the mechanism of action. Intra-arterial infusion chemotherapy combined with MPA may also be valuable in treating metastatic liver tumors and recurrent lesions in the regional lymph nodes such as supraclavicular tumors. A high response rate was obtained in the chemo-endocrine therapy when combined with MPA as a pretreatment. Thus, MPA may be expected to be available as a systemic therapy, too. In the future, a new development in the field of intra-arterial infusion chemotherapy may be achieved by utilizing a combination of angiogenesis inhibitors and peripheral blood stem cell transplantation.

Adult↗

Correlation of heat shock protein 70 expression with estrogen receptor levels in invasive human breast cancer.

The authors studied the role of 70-Kd heat shock protein (HSP70) in the progression of breast cancer by examining the correlation between the expression of HSP70 and epidermal growth factor receptor, c-erbB-2, p53, and estrogen receptor in 124 cases of invasive primary human breast cancers. Positivity of an anti-HSP70 monoclonal antibody, C92, was closely associated with the elevation of estrogen receptor (P < .008), whereas it inversely correlated with the expression of p53 (P < .01). In addition, the expression of HSP70 correlated inversely with the expression of epidermal growth factor receptor, although the correlation was not statistically significant (P = .06). These results suggest that the expression of HSP70 plays a role in the progression of human breast cancer.

Breast Neoplasms↗

Immunohistochemical detection of p53 protein in borderline and malignant serous ovarian tumors.

The p53 suppressor gene protein expression was studied with immunoperoxidase staining in 61 serous tumors of the ovary. Twenty four (53%) of the 45 histologically malignant tumors were positive for p53, whereas neither the six benign nor the 10 tumors of borderline malignancy showed positive staining, except for one borderline tumor with atypia and increased mitotic activity. Therefore, p53 immunostaining may have diagnostic value in discriminating between borderline and malignant serous ovarian tumors. Malignant ovarian tumors with negative staining for p53 were associated with a 67% 3-year crude survival rate as compared with only an 18% 3-year survival rate if p53 staining was positive (p = 0.002). In a multivariate analysis, the p53 staining was the most important prognostic factor, with a relative risk of 4.2 (95% confidence interval, 1.8-9.9) followed by the FIGO stage (2.1, 1.3-3.5). We conclude that immunohistochemical p53 suppressor gene protein expression analysis has both diagnostic and prognostic value.

Adult↗

[The action of non-depolarizing muscle relaxants on nerve terminal of motor endplate--relationship between run-down of endplate potentials and fading tension response].

The classical view of the neuromuscular transmission is that non-depolarizing muscle relaxants (MRs) enhance run-down of the endplate potentials (epps) by blocking pre-junctional nicotinic acetylcholine (ACh) receptors. Several recent investigations, when extended to pharmacology, have provided evidence to suggest the existence of other types of enhancement of run-down of epps by MRs; the enhancement of epps occurs without reduction of ACh release in the presence of MRs. It has been generally accepted that the enhancement of run-down of epps causes the tetanic fade of tension response. However, recent evidence indicates that run-down of epps does not always cause this wane in tension. The electrophysiological mechanism of run-down of epps at the neuromuscular junction and the relationship between that phenomenon and the extent of reduction of tension response are described based on a review of literature and our current investigations.

Acetylcholine↗

[The significance of intra-arterial infusion therapy for neoadjuvant chemotherapy].

Arterial infusion therapy with anticancer drugs is now attracting attention as a valuable modality for locally advanced breast cancer. Since 1977, we have used this therapy in 122 patients with primary breast cancer. The present report mainly discusses the clinical and histological response as well as the prognosis. The anticancer drugs were mainly given by two routes, infusion into the internal mammary artery and the subclavian artery. Continuous infusion of 5-FU and intermittent injections of MMC, ADR, 4'-epi-ADR and THP-ADR were jointly or individually made in each artery. Clinical response, defined as CR + PR, was noted in 48.4% of 5-FU group and 72.7% of ADR-MMC group. Histological response according to Shimosato Criteria, defined as grade IIb or better, appeared in 45.2% of main tumors and 25.4% of metastatic lymph nodes in the 5-FU group, and 70.9% main tumors and 46.3% of metastatic lymph nodes in the ADR-MMC group. The non-infusion group contained 27.7% of stage IIIb, against 72.2% in the infusion group. The 5-year overall survival rates were non-infusion group 62%, 5-FU group 34.1% and ADR-MMC group 66.2%. A significant difference was seen between the 5-FU infusion group and the ADR-MMC group (p = 0.03). Administration of high dose medroxy progesterone acetate for two weeks and 4'-epi-ADR infusion chemotherapy resulted in an excellent histological response. This combination therapy is a promising neoadjuvant chemo-endocrine therapy for advanced breast cancer.

Antineoplastic Combined Chemotherapy Protocols↗

[Neuromuscular effects of vecuronium in patients receiving long-term administration of dantrolene].

We report two patients who received anesthesia using vecuronium (VCB) subsequent to long-term treatment with orally administered dantrolene. The present data suggest that these doses used of dantrolene do not prolong the duration of neuromuscular blockade induced by VCB. An 8 year old boy was given general anesthesia after medication with 20 mg.day-1 of dantrolene orally for two years. Anesthesia was induced with thiamylal and maintained with nitrous oxide in oxygen and halothane. The neuromuscular blocking effect of vecuronium was evaluated using mechanomyogram (Myograph 2000, Biometer). The potency of VCB was in the normal range and the duration and recovery time were not prolonged. A 49 year old male had been treated with 50 mg.day-1 of orally administered dantrolene for several years prior to the operation. Anesthesia was induced with thiamylal and maintained with nitrous oxide in oxygen and isoflurane. The neuromuscular blocking effect of VCB was monitored by the same method as described above. Again, there was no apparent prolongation of neuromuscular blocking action of VCB. Evidently, VCB may be used in the clinic under standard conditions of neuromuscular monitoring in patients under previous long-term treatment with dantrolene.

Administration, Oral↗

[A microelectrode study of the antagonism of d-tubocurarine induced neuromuscular blockade by edrophonium and neostigmine].

It has been reported clinically that edrophonium (EDR) has a more potent antagonistic effect on the fade of twitch tension and a less potent antagonistic effect on the depressed single twitch force induced by muscle relaxants than does neostigmine (NST). However, the details of the mechanism have not yet been clarified. In this experiment, to compare the antagonistic effect of EDR and NST on the neuromuscular blocking effect of dTc, the recovery from dTc induced neuromuscular blocking effect on both the postjunctional membrane and the motor nerve terminal with EDR or NST was studied using intracellular recording techniques in rat phrenic nerve-hemidiaphragm preparations. The preparation was constantly perfused with physiological saline solution at room temperature. To determine the ACh sensitivity of the postjunctional membrane, ACh potentials were elicited and recorded. To determine the quantum release of ACh from the motor nerve terminal and its rundown, endplate potentials (EPPs) were elicited at 2Hz and recorded. ACh sensitivity was increased with EDR and NST in a dose dependent manner. The extent of increased ACh sensitivity with EDR 10(-6)M was almost equal to that with NST 10(-7)M. In this experiment, these concentrations were used to compare the antagonistic effect of EDR and NST on the effect of dTc 10(-6)M. The depressed ACh sensitivity with dTc was reversed with EDR and NST. The extent of restoration with NST was about three times that with EDR. The quantum release of ACh was increased and rundown was depressed with EDR, but NST had no effect. After pretreatment with dTc, neither EDR nor NST increased the decreased quantum release of ACh nor reversed the enhanced rundown induced by dTc. But under the same condition, both EDR and NST reversed the ACh sensitivity depressed with dTc. These results demonstrate that neither EDR nor NST were able to affect the decreased quantum release of ACh nor the enhanced rundown induced by dTc. The results also suggest that the reversal of fade of twitch tension with EDR and NST does not always result from recovery of rundown of EPP amplitude.

Animals↗

[A case of inflammatory breast cancer treated with medroxyprogesterone acetate (MPA) in combination with intra-arterial infusion chemotherapy].

A 55-year-old female with severe inflammatory breast cancer was treated with the combined use of MPA and the intraarterial infusion chemotherapy. One cycle consisted of 4'-epi-adriamycin; 210 mg (day 1, 4 and 8) and daily administration of MPA; 1,200 mg. A marked shrinkage of the tumor was obtained with this treatment. The regressive change was noted not only in the primary lesion but in lymph nodes of the axillary region. Therefore, the combined use of MPA with intra-arterial infusion chemotherapy may well contribute to the treatment of inflammatory breast cancer.

Antineoplastic Combined Chemotherapy Protocols↗

[Malignant hyperthermia; two cases of MH in the presence of general anesthesia and performing caffeine contracture test].

In the present report we described two cases of malignant hyperthermia under halothane anesthesia. Case 1; A 54-year-old, 58 kg-male was scheduled for the operation of giant arterio-venous malformation. Anesthesia was induced with thiamylal, fentanyl and pancuronium, and maintained with oxygen, nitrous oxide and halothane. The patient was subjected to halothane inhalation for 26 hours prior to the development of the malignant hyperthermia. Although body temperature rose to 41 degrees C, it returned to normal with the administration of 280 mg of dantrolene and systemic cooling. Case 2; A 31-year-old, 68 kg-female was scheduled for tonsillectomy. Anesthesia was induced with thiamylal, oxygen, nitrous oxide and halothane. After the administration of 70 mg of SCC, marked muscular rigidity occurred and endotracheal intubation was impossible. The operation was postponed. Two months after the first anesthesia, operation was successfully performed under NLA with droperidol and fentanyl. Caffeine contracture test was performed in each case by skinned fiber method and the result showed that the sensitivity to caffeine increased in the isolated skeletal muscle fiber bundles from these patients. Thresholds of caffeine contracture of these skinned fiber bundles were all lower than 5mM caffeine.

Adult↗

[Intra-arterial infusion chemotherapy of advanced breast cancer--effects and side effects of adriamycin, 4'-epi-adriamycin and THP-adriamycin].

In 34 patients with primary advanced breast cancer, intra-arterial administration of ADR (50 mg X 3, total dose 150 mg, 10 cases), 4' epi ADR (50 mg X 3, 150 mg, 8 cases; 70 mg X 3, 210 mg, 10 cases) and THP-ADR (50 mg X 3, 150 mg, 6 cases) was performed, and its effects and side effect were analyzed. The clinical and histological response rate were superior in the ADR (150 mg) regimen and 4'-epi-ADR (150 mg) regimen. Signs of systemic toxicity such as gastrointestinal disorders, leukocytopenia and thrombocytopenia were the side effects in patients treated with THP-ADR, but the frequency of alopecia was lower. No cardiotoxicity was recorded in any of the patients. These results indicated that 4'-epi-ADR given the total dose of 150 mg in a single dosage of 50 mg was the most effective agent in intra-arterial infusion chemotherapy for advanced breast cancer.

Alopecia↗

[Intraarterial chemo-embolization with adriamycin containing albumin microspheres].

For local treatment of inflammatory breast cancer and recurrent breast cancers with liver metastasis, we applied intraarterial infusion chemoembolization therapy utilizing albumin microspheres containing adriamycin (ADM-ms), which was developed by Morimoto. In this study, there were 2 cases of inflammatory breast cancer and 3 cases of recurrent breast cancers with liver metastasis. Arterial canulation of primary breast cancer were made through both arteries, the internal mammary artery and lateral thoracic artery, which were feeding arteries of the breast. ADM-ms was injected into both arteries and its tumor effect was evaluated clinically and histologically. Remarkable reduction in tumor size was recognized. Histologic examination of resected specimens revealed extensive fibrosis in the center of the primary tumors. A few cancer cells, degenerated in various degrees, were found remaining in the periphery of the necrotic mass. Local side effects of the microspheres were skin disturbances such as pain, redness and blistering. ADM-ms was injected into the hepatic artery for the liver metastatic cases, and its antitumor effect was evaluated by CT scan or echography. Effective reduction in tumor size was only recognized in one case. No serious systemic side effects, not recognized in any case. Our report reviews the effectiveness of this therapy as a preliminary procedure for surgical treatment of inoperable inflammatory breast cancer.

Adult↗

[Intra-arterial infusion chemotherapy with anticancer agents for advanced breast cancer--effect and toxicity of mitomycin C and adriamycin].

In 23 cases of primary advanced breast cancer, intra-arterial infusion chemotherapy of Adriamycin (ADR) and Mitomycin C (MMC), which were injected jointly or individually, was performed and its effects and side effects were studied. As for the clinical effects, the response rate (CR + PR) was 73.9% (17/23 cases) and the histological response rate (greater than grade IIb) was 82.6% (19/23 cases). ADR alone (100-150 mg) and MMC (28 mg) + ADR (42 mg) combined regimens were especially superior in both their clinical and histological effects. In metastatic lymph nodes, the histological response rate was 78.9% (15/19 cases). As for the side effects, in the cases treated with MMC, bone marrow suppression such as leukocytopenia and thrombocytopenia was remarkable and took a long time to recover. The above results suggested that the most effective regimen for primary advanced breast cancer using intra-arterial infusion chemotherapy is ADR alone, in single doses of 50 mg up to a total dose of 150-200 mg. Histological examination of the effective cases revealed that the central region of the tumor was more markedly recrotic than the periphery. It was suggested that the grade of the effects on tumor tissues is related to the mechanism of anticancer agents.

Alopecia↗